Dian Diagnostics Group Co.,Ltd.

¥21.44As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300244Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (2.85%)
Div yield 1.63%
ROE 6.79%
Diagnostics & Research
Beta (5Y) 0.69
PE TTM 27.90
TSR TTM 34.15%
Mkt cap ¥13.10B
ROIC 8.36%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥22
2.36%
141.43%
Hold 4|4|5|8|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.46
0.49
0.51
0.54
28.60%
23.34%
16.86%
17.71%
Revenue¥M
676.7
660.4
674.8
676.8
5.85%
5.28%
3.40%
2.65%
Peers (US$1.964B)
Cap (US$)
PE
1.960B
47.34x
1.125B
30.08x
1.972B
13.83x
Capital
TTM
5Y
10Y
Leveragex
2.064
(0.156)
(0.143)
EBIT/Intx
0.274
0.573
0.499
Own earn%
(413.75)
(89.28)
(82.02)
Sh yield%
44.15
29.13
30.14
Owners
Insiders/Inst%
8.74
29.43
Short interest%
4.81
SBC / revenue%
4.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
0–5
$1 testx
−0.1
Incr. ROIC%
23